Literature DB >> 17656075

Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsification.

Hong Yuan1, Lei-Lei Wang, Yong-Zhong Du, Jian You, Fu-Qiang Hu, Su Zeng.   

Abstract

Nanostructured lipid carriers (NLC) made from mixtures of solid and spatially incompatible liquid lipids were prepared by melt-emulsification. Their drug loading capacity and releasing properties of progesterone were compared with those of solid lipid nanoparticles (SLN), and the NLC prepared by solvent diffusion method. Monostearin (MS) and stearic acid (SA) were used as solid lipid, whilst the oleic acid (OA) was used as liquid lipid. Properties of carriers such as the particle size and its distribution, drug loading, drug encapsulation efficiency and drug release behavior were investigated. As a result, the drug encapsulation efficiencies were improved by adding the liquid lipid into the solid lipid of nanoparticles. The drug release behavior could be adjusted by the addition of liquid lipid, and the NLC with higher OA content showed the faster rate of drug releasing. NLC had higher efficiency of encapsulation and slower rate of drug release than those of NLC prepared by solvent diffusion method. On the other hand, the NLC with higher drug loading was obtained, though the drug encapsulation efficiency was decreased slightly due to the increase of the amount of drug. The NLC modified with polyethylene glycol (PEG) was also prepared by using polyethylene glycol monostearate (PEG-SA). It was observed that the incorporation of PEG-SA reduced the drug encapsulation efficiency, but increased the rate of drug release. A sample with almost complete drug release in 24h was obtained by modifying with 1.30mol% PEG-SA. It indicated that the modified NLC was a potential drug delivery system for oral administration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17656075     DOI: 10.1016/j.colsurfb.2007.06.011

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  23 in total

Review 1.  Nanocarrier for poorly water-soluble anticancer drugs--barriers of translation and solutions.

Authors:  Mayuri Narvekar; Hui Yi Xue; June Young Eoh; Ho Lun Wong
Journal:  AAPS PharmSciTech       Date:  2014-04-02       Impact factor: 3.246

Review 2.  Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic.

Authors:  Anu Puri; Kristin Loomis; Brandon Smith; Jae-Ho Lee; Amichai Yavlovich; Eliahu Heldman; Robert Blumenthal
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2009       Impact factor: 4.889

Review 3.  Applications and perspectives of polyphenol-loaded solid lipid nanoparticles and nanostructured lipid carriers for foods.

Authors:  Eunghee Kim; Choongjin Ban; Sang-Oh Kim; Seokwon Lim; Young Jin Choi
Journal:  Food Sci Biotechnol       Date:  2022-05-20       Impact factor: 3.231

4.  Efavirenz oral delivery via lipid nanocapsules: formulation, optimisation, and ex-vivo gut permeation study.

Authors:  Jaleh Varshosaz; Somayeh Taymouri; Ali Jahanian-Najafabadi; Arezoo Alizadeh
Journal:  IET Nanobiotechnol       Date:  2018-09       Impact factor: 1.847

5.  Nanoparticle-mediated macrophage targeting-a new inhalation therapy tackling tuberculosis.

Authors:  Shaimaa Makled; Nabila Boraie; Noha Nafee
Journal:  Drug Deliv Transl Res       Date:  2021-06       Impact factor: 4.617

6.  Ion exchange column technique as a novel method for evaluating the release of docetaxel from different lipid nanoparticles.

Authors:  Mohamed Dawoud; Randa Abdou
Journal:  Drug Deliv Transl Res       Date:  2021-03-25       Impact factor: 4.617

7.  Modification of polyethylene glycol onto solid lipid nanoparticles encapsulating a novel chemotherapeutic agent (PK-L4) to enhance solubility for injection delivery.

Authors:  Yi-Ping Fang; Pao-Chu Wu; Yaw-Bin Huang; Cherng-Chyi Tzeng; Yeh-Long Chen; Yu-Han Hung; Ming-Jun Tsai; Yi-Hung Tsai
Journal:  Int J Nanomedicine       Date:  2012-09-17

8.  Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken design.

Authors:  Jifu Hao; Xinsheng Fang; Yanfang Zhou; Jianzhu Wang; Fengguang Guo; Fei Li; Xinsheng Peng
Journal:  Int J Nanomedicine       Date:  2011-04-06

9.  Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery.

Authors:  Patrícia Severino; Tatiana Andreani; Ana Sofia Macedo; Joana F Fangueiro; Maria Helena A Santana; Amélia M Silva; Eliana B Souto
Journal:  J Drug Deliv       Date:  2011-11-24

10.  In-vitro and in-vivo evaluation of chitosan-based thermosensitive gel containing lorazepam NLCs for the treatment of status epilepticus.

Authors:  Somayeh Taymouri; Mohsen Minaiyan; Farnaz Ebrahimi; Naser Tavakoli
Journal:  IET Nanobiotechnol       Date:  2020-04       Impact factor: 1.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.